MedPath

Qualitative Study on Detection & Tx of NSCLC in Pts w/ a History of Alcohol or SUD

Not yet recruiting
Conditions
Lung Non-Small Cell Carcinoma
Registration Number
NCT07186699
Lead Sponsor
University of Southern California
Brief Summary

This study will attempt to identify social facilitators and barriers to detection and treatment of non-small cell lung cancer in order to learn how a history of substance abuse or alcohol use impacts care for non-small cell lung cancer.

Detailed Description

PRIMARY OBJECTIVE:

I. To identify social facilitators and barriers to detection and treatment of NSCLC by interviewing a diverse group of patients at Keck, Los Angeles General Medical Center, and Norris Cancer Center with alcohol or substance use disorder history.

OUTLINE: This is an observational study.

Patients participate in a semi-structured interview and may participate in a follow-up focus group interview in which preliminary findings are shared and feedback is elicited on study.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
45
Inclusion Criteria
  • * Adults β‰₯ 18 years of age

    • Histopathologic or cytologic diagnosis of NSCLC
    • Received or receiving curative intent treatment (e.g. surgery, radiation therapy, systemic therapy)
    • History of alcohol use or substance use disorder (other than tobacco use disorder) within the past 10 years, predating the cancer diagnosis
    • Ability to understand and the willingness to sign a written informed consent
    • English or Spanish speaking. Due to need to conduct semi-structured interviews which can develop into free-flowing conversations we need both participant and interviewer to be fluent
Exclusion Criteria
  • Patients with cognitive disability unable to maintain 30-60 minute conversation

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Thematic saturationUp to 3 years

Will use a Danaher framework to approach analyze interview data using NVivo software (NVivo version 11.0, QSR International). Each interview will be analyzed to identify broad themes.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Los Angeles General Medical Center

πŸ‡ΊπŸ‡Έ

Los Angeles, California, United States

USC / Norris Comprehensive Cancer Center

πŸ‡ΊπŸ‡Έ

Los Angeles, California, United States

Los Angeles General Medical Center
πŸ‡ΊπŸ‡ΈLos Angeles, California, United States
Sandy Tran
Contact
323-865-3935
sandy.tran@med.usc.edu
Brooks V. Udelsman
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.